Product image of Zynlonta (Loncastuximab Tesirine) supplied by GNH India

Zynlonta

Active Ingredient:
Loncastuximab Tesirine
Origin:
EU

Zynlonta (Loncastuximab Tesirine)

Zynlonta (loncastuximab tesirine) is an FDA-approved prescription therapy for relapsed or refractory large B-cell lymphoma. Administered intravenously, it targets CD19-positive cancer cells. This targeted treatment is designed for patients who have not responded to prior therapies. Always consult a healthcare provider for suitability.

Manufacturer / TM Owner

Swedish Orphan Biovitrum Ab (Publ)

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Zynlonta is used to treat relapsed or refractory large B-cell lymphoma in adults who have received at least two prior systemic therapies. It is indicated specifically for diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma. This medication targets CD19, a protein found on certain cancer cells, helping to slow disease progression. It is not a first-line treatment and is reserved for patients who have exhausted other options.

Side Effects

  • Patients receiving Zynlonta may experience effects related to its action on cancer cells, such as changes in blood cell counts or liver function. Common effects can include fatigue, nausea, or swelling in the limbs. Some individuals may notice skin reactions or changes in appetite. These effects vary by patient and should be monitored by a healthcare professional.

Precautions & Warnings

  • Zynlonta is administered under medical supervision due to its potent effects. Patients should inform their doctor of all medications, including over-the-counter and supplements, before starting treatment. Regular blood tests are typically required to monitor for potential complications. Avoiding live vaccines during treatment may be recommended.

Avoid Interactions

  • Zynlonta may interact with other drugs that affect liver enzymes, such as CYP3A inhibitors or inducers, which can alter its effectiveness. Combining it with strong immunosuppressants could increase infection risk. Alcohol and certain herbal supplements may also interact unpredictably. Always disclose all medications to your healthcare provider.

Frequently Asked Questions

Zynlonta is used to treat relapsed or refractory large B-cell lymphoma, including diffuse large B-cell lymphoma (DLBCL), in adults who have tried other therapies.

Zynlonta is given as an intravenous infusion by a healthcare professional in a clinical setting.

Common effects may include fatigue, nausea, swelling, or changes in blood cell counts. These should be discussed with a doctor.

Zynlonta may interact with certain drugs. Always inform your healthcare provider about all medications you are taking before starting treatment.

No, Zynlonta is approved for patients who have not responded to at least two prior systemic therapies.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated:

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Loncastuximab Tesirine

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT